Literature DB >> 15711575

Atypical transcriptional regulators and cofactors of PPARgamma.

S Miard1, L Fajas.   

Abstract

Regulation of peroxisome proliferator-activated receptor gamma (PPARgamma) activity is the result of several events. The first control level is the regulation of the expression of PPARgamma. Examples of this regulation, during adipogenesis, is the transactivation of the PPARgamma promoter by transcription factors of the classical pathway, such as C/EBPs or ADD1/SREBP1, but also newly identified factors, such as E2Fs. When preadipocytes re-enter the cell cycle, PPARgamma expression is induced coincident with an increase in DNA synthesis, suggesting the involvement of the E2F family of cell cycle regulators. E2F1 induces PPARgamma transcription during clonal expansion, whereas E2F4 represses PPARgamma expression during terminal adipocyte differentiation. Hence, E2Fs represent the link between proliferative signaling pathways, triggering clonal expansion, and terminal adipocyte differentiation through regulation of PPARgamma expression. A second regulatory level of PPARgamma action is interaction with cofactors. We will focus our attention on the atypical PPARgamma modulators. We have described an interaction between PPARgamma and the retinoblastoma protein, RB, which is both dependent upon ligand binding by PPARgamma and upon the phosphorylation status of RB. The interaction between PPARgamma and RB decreases the transcriptional activity of PPARgamma through recruitment of the histone deacetylase HDAC3. Inhibition of HDAC activity consequently results in a strong activation of PPARgamma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15711575     DOI: 10.1038/sj.ijo.0802906

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  18 in total

1.  Akt-dependent Skp2 mRNA translation is required for exiting contact inhibition, oncogenesis, and adipogenesis.

Authors:  Veronique Nogueira; Deepa Sundararajan; Jennifer M Kwan; Xiao-ding Peng; Neha Sarvepalli; Nahum Sonenberg; Nissim Hay
Journal:  EMBO J       Date:  2012-02-03       Impact factor: 11.598

2.  Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor {gamma}.

Authors:  Ui-Hyun Park; Seung Kew Yoon; Taesun Park; Eun-Joo Kim; Soo-Jong Um
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

3.  Inhibition of HDAC3 promotes ligand-independent PPARγ activation by protein acetylation.

Authors:  Xiaoting Jiang; Xin Ye; Wei Guo; Hongyun Lu; Zhanguo Gao
Journal:  J Mol Endocrinol       Date:  2014-06-30       Impact factor: 5.098

4.  Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis.

Authors:  Shanmugam Muruganandan; Sebastian D Parlee; Jillian L Rourke; Matthew C Ernst; Kerry B Goralski; Christopher J Sinal
Journal:  J Biol Chem       Date:  2011-05-14       Impact factor: 5.157

5.  Keratinocyte aquaporin-3 expression induced by histone deacetylase inhibitors is mediated in part by peroxisome proliferator-activated receptors (PPARs).

Authors:  Rong Yang; Shinjini Chowdhury; Vivek Choudhary; Xunsheng Chen; Wendy B Bollag
Journal:  Exp Dermatol       Date:  2020-02-18       Impact factor: 3.960

Review 6.  Why do anti-inflammatory therapies fail to improve insulin sensitivity?

Authors:  Zhan-guo Gao; Jian-ping Ye
Journal:  Acta Pharmacol Sin       Date:  2011-10-31       Impact factor: 6.150

7.  Ablation of XP-V gene causes adipose tissue senescence and metabolic abnormalities.

Authors:  Yih-Wen Chen; Robert A Harris; Zafer Hatahet; Kai-ming Chou
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

8.  Integrative analysis of many weighted co-expression networks using tensor computation.

Authors:  Wenyuan Li; Chun-Chi Liu; Tong Zhang; Haifeng Li; Michael S Waterman; Xianghong Jasmine Zhou
Journal:  PLoS Comput Biol       Date:  2011-06-16       Impact factor: 4.475

9.  PPARgamma and MEK Interactions in Cancer.

Authors:  Elke Burgermeister; Rony Seger
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

10.  Energy Balance, Myostatin, and GILZ: Factors Regulating Adipocyte Differentiation in Belly and Bone.

Authors:  Xingming Shi; Mark Hamrick; Carlos M Isales
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.